JWH-015

From WikiMD's Wellnesspedia

JWH-015 is a chemical from the naphthoylindole family, which acts as a cannabinoid receptor type 2 (CB2) agonist. It was developed by the team led by John W. Huffman at Clemson University.

Chemistry[edit | edit source]

JWH-015 is part of the naphthoylindole family of compounds, which are known for their activity on the cannabinoid receptors. It is a CB2 agonist, meaning it binds to this receptor and produces a biological response.

Pharmacology[edit | edit source]

JWH-015 acts as a CB2 agonist. The CB2 receptor is primarily found in the immune system, and its activation results in anti-inflammatory and potentially anti-cancer effects. However, the exact mechanisms of action of JWH-015 are still under investigation.

Research[edit | edit source]

Research on JWH-015 has primarily focused on its potential therapeutic uses. Studies have suggested that it may have anti-inflammatory and anti-cancer properties, although more research is needed to confirm these findings.

See also[edit | edit source]

References[edit | edit source]


JWH-015 Resources

Find a healthcare provider anywhere in the world quickly and easily!

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD